Bifidobacterium and Ocrevus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bifidobacterium (bifidobacteria) and Ocrevus (ocrelizumab). Common drug interactions include fatigue among females and dyspepsia among males.

The phase IV clinical study analyzes what interactions people have when they take Bifidobacterium and Ocrevus. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Bifidobacterium?

Bifidobacterium has active ingredients of bifidobacteria. eHealthMe is studying from 5,013 Bifidobacterium users. Check the latest studies of Bifidobacterium.

What is Ocrevus?

Ocrevus has active ingredients of ocrelizumab. eHealthMe is studying from 56,583 Ocrevus users. Check the latest studies of Ocrevus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

19 people who take Bifidobacterium and Ocrevus together, and have interactions are studied.

Bifidobacterium and Ocrevus drug interactions.

What are the common drug interactions of Bifidobacterium and Ocrevus, by gender? *:

female:

Fatigue (feeling of tiredness)
Nasopharyngitis (inflammation of the nasopharynx)
Clostridial infection (infectious conditions by clostridium bacteria)
Herpes virus infection
Infection
Nephritis (inflammation of the nephrons in the kidneys)
Abdominal discomfort
Gingivitis (inflammation of gums)
Cough
Apathy

male:

Dyspepsia (indigestion)
Dyspnoea (difficult or laboured respiration)
Nausea (feeling of having an urge to vomit)
Flushing (the warm, red condition of human skin)
B-lymphocyte count decreased
Blood testosterone decreased
Micturition urgency (urgency to pass the urine)
Osteoporosis (bones weak and more likely to break)
Dizziness
Fatigue (feeling of tiredness)

What are the common drug interactions of Bifidobacterium and Ocrevus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Fatigue (feeling of tiredness)
Nasopharyngitis (inflammation of the nasopharynx)
Clostridial infection (infectious conditions by clostridium bacteria)
Herpes virus infection
Infection
Nephritis (inflammation of the nephrons in the kidneys)
Abdominal discomfort
Gingivitis (inflammation of gums)
Apathy
Back pain

40-49:

Blood testosterone decreased
Micturition urgency (urgency to pass the urine)
Osteoporosis (bones weak and more likely to break)
Dizziness
Fatigue (feeling of tiredness)
Hypokinesia (decreased bodily movement)
Nausea (feeling of having an urge to vomit)
Bladder dysfunction
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Neuralgia (pain in one or more nerves)

50-59:

Anxiety
Cataract (clouding of the lens inside the eye)
Cerebral atrophy (decrement in size of brain)
Inflammation
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Spinal cord injury

60+:

n/a

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 12 people, 63.16%
Nephritis (inflammation of the nephrons in the kidneys): 7 people, 36.84%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 31.58%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 31.58%
Drowsiness: 4 people, 21.05%
Constipation: 2 people, 10.53%
Immunodeficiency: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Bifidobacterium and Ocrevus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously